STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $423,000 | -52.5% | 87,400 | +4.3% | 0.00% | -100.0% |
Q4 2019 | $891,000 | +3.6% | 83,800 | +1.5% | 0.00% | 0.0% |
Q3 2019 | $860,000 | -12.9% | 82,600 | +28.3% | 0.00% | 0.0% |
Q2 2019 | $987,000 | +9.1% | 64,400 | -8.5% | 0.00% | 0.0% |
Q1 2019 | $905,000 | +93.4% | 70,400 | +42.8% | 0.00% | 0.0% |
Q4 2018 | $468,000 | +198.1% | 49,300 | +540.3% | 0.00% | 0.0% |
Q1 2014 | $157,000 | +51.0% | 7,700 | +45.3% | 0.00% | – |
Q4 2013 | $104,000 | – | 5,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |